Evidence map›Paper›PMID 40286985›Full record

ArticleOphthalmology. Retina2025

Detection of Center-Involved Diabetic Macular Edema With Visual Impairment Using Multimodal Artificial Intelligence Algorithms.

Tien-En Tan, Yi Pin Ng, Claire Calhoun, Jia Quan Chaung, Jie Yao, Yan Wang, Liangli Zhen, Xinxing Xu, Yong Liu, Rick S M Goh and 5 more

Abstract read
In one paragraph

Article in Ophthalmology. Retina, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Artificial intelligence in diabetic retinopathy: from automated screening to risk-stratified care.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tien-En TanSingapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-National University of Singapore Medical School, Singapore.
Yi Pin NgInstitute of High Performance Computing, Agency for Science, Technology and Research (A∗STAR), Singapore.
Claire CalhounJaeb Center for Health Research, Tampa, Florida.
Jia Quan ChaungSingapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Jie YaoSingapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-National University of Singapore Medical School, Singapore.
Yan WangInstitute of High Performance Computing, Agency for Science, Technology and Research (A∗STAR), Singapore.
Liangli ZhenInstitute of High Performance Computing, Agency for Science, Technology and Research (A∗STAR), Singapore.
Xinxing XuInstitute of High Performance Computing, Agency for Science, Technology and Research (A∗STAR), Singapore.
Yong LiuInstitute of High Performance Computing, Agency for Science, Technology and Research (A∗STAR), Singapore.
Rick S M GohInstitute of High Performance Computing, Agency for Science, Technology and Research (A∗STAR), Singapore.
Gabriele PiccoliEye Clinic, IRCCS MultiMedica, Milan, Italy.
Stela VujosevicEye Clinic, IRCCS MultiMedica, Milan, Italy; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Gavin S W TanSingapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-National University of Singapore Medical School, Singapore.
Jennifer K SunJoslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology, Boston, Massachusetts.
Daniel S W TingSingapore Eye Research Institute, Singapore National Eye Centre, Singapore; Duke-National University of Singapore Medical School, Singapore. Electronic address: daniel.ting45@gmail.com.

Funding

DRCR Retina NetworkUG1EY014231 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI Adam R Glassman, DANIEL F MARTIN · 2019 to 2026
$75.4M
NEI NIH HHS UG1 EY014231
6 · The paper itself

Abstract

purposeTo develop artificial intelligence (AI) models for automated detection of center-involved diabetic macular edema (CI-DME) with visual impairment using color fundus photographs (CFPs) and OCT scans.

designArtificial intelligence effort using pooled data from multicenter studies.

participantsData sets consisted of diabetic participants with or without CI-DME, who had CFP, OCT, and best-corrected visual acuity (BCVA) obtained after manifest refraction. The development data set was from DRCR Retina Network clinical trials, external testing data set 1 was from the Singapore National Eye Centre, Singapore, and external testing data set 2 was from the Eye Clinic, IRCCS MultiMedica, Milan, Italy.

methodsArtificial intelligence models were trained to detect CI-DME, visual impairment (BCVA 20/32 or worse), and CI-DME with visual impairment, using CFPs alone, OCTs alone, and both CFPs and OCTs together (multimodal). Data from 1007 eyes were used to train and validate the algorithms, and data from 448 eyes were used for testing.

main outcome measuresArea under the receiver operating characteristic curve (AUC) values.

resultsIn the primary testing set, the CFP model, OCT model, and multimodal model had AUCs of 0.848 (95% confidence interval [CI], 0.787-0.900), 0.913 (95% CI, 0.870-0.947), and 0.939 (95% CI, 0.906-0.964), respectively, for detection of CI-DME with visual impairment. In external testing data set 1, the CFP, OCT, and multimodal models had AUCs of 0.756 (95% CI, 0.624-0.870), 0.949 (95% CI, 0.889-0.989), and 0.917 (95% CI, 0.837-0.979), respectively, for detection of CI-DME with visual impairment. In external testing data set 2, the CFP, OCT, and multimodal models had AUCs of 0.881 (95% CI, 0.822-0.940), 0.828 (95% CI, 0.749-0.905), and 0.907 (95% CI, 0.852-0.952), respectively, for detection of CI-DME with visual impairment.

conclusionsThe AI models showed good diagnostic performance for the detection of CI-DME with visual impairment. The multimodal (CFP and OCT) model did not offer additional benefit over the OCT model alone. If validated in prospective studies, these AI models could potentially help to improve the triage and detection of patients who require prompt treatment. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Artificial IntelligenceDiabetic RetinopathyFluorescein AngiographyMacular EdemaTomography, Optical CoherenceVision DisordersAgedDatasets as TopicFemaleFundus OculiHumansMaleMiddle AgedMulticenter Studies as TopicMultimodal ImagingRetrospective StudiesAICI-DMEDiabetic macula edemaDMEVisual impairment

Identifiers

PMID40286985
PMCPMC12414794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.